Clinical Trials in Florida

Showing 901-920 of 10,975 trials

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

NCT06384807

This is a Phase 1/2, first in human (FIH), open-label, multicenter study of BHV-1510 monotherapy and in Combination with Cemiplimab in participants with previously treated, advanced solid tumors.

Solid Tumor

Biohaven Therapeutics Ltd.500 participantsStarted Apr 2024

Duarte, California, United States • La Jolla, California, United States • Palo Alto, California, United States +14 more locations

RECRUITINGPhase 349 miles

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

NCT06679140

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease. Eligible participants will be randomly assigned (by chance) to receive ibuzatrelvir or matching placebo orally for 5 days. Co-administration of locally available standard of care is allowed. The total duration of the study is around 6 months.

COVID-19 SARS-CoV-2 Infection

Pfizer2,330 participantsStarted Dec 2024

Little Rock, Arkansas, United States • Bakersfield, California, United States • Inglewood, California, United States +231 more locations

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Find Trials by Condition in Florida

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

A Just-in-Time Adaptive Intervention for Child and Family Mental Health

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision